nDatalyze Corp. specializes in machine learning solutions for predicting mental health conditions. Its strengths include a high current ratio of 21.60, indicating excellent liquidity, and a debt-free balance sheet, which reduces financial risk. However, concerns arise from negative ROE and ROA, suggesting inefficiencies in generating returns. The stock's recent decline of 12.50% may reflect market skepticism despite its innovative approach in the healthcare sector. Overall, while the company has solid liquidity, its profitability metrics warrant caution.
Loading financial metrics...
Revenue fell 98.9% year-over-year from $84K to $887. The decline has persisted for multiple quarters.
Company posted a loss of $-387K over the last year, representing 43676.6% of revenue.
Debt-free balance sheet with a solid cash position, providing significant financial flexibility.
Excellent liquidity with current ratio of 21.6x ensures operational stability.
Low debt-to-revenue ratio of 0.0% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Health Information Services companies of a similar size
Based on 2025-Q2 (May 31, 2025)